Ferric carboxymaltose

also known as Ferinject · FCM · Injectafer · iron carboxymaltose · ferric(III) carboxymaltose · ferricarboxymaltose · Iron(III)carboxymaltose · Carboximaltosa ferrica · +7 more

Other / unclassified

Developed for: iron deficiency anemia · anemia · disorder of iron metabolism and transport · heart failure · systolic heart failure · iron metabolism disease · restless legs syndrome · acute myocardial infarction
+40 more
· aortic valve stenosis · cancer · chronic obstructive pulmonary disease · coronary artery disorder · deficiency anemia · diastolic heart failure · inflammatory bowel disease · osteoarthritis, hip · acute coronary syndrome · atrial fibrillation · bone disorder · celiac disease · chemotherapy-induced toxicity · chronic kidney disease · colon carcinoma · colorectal carcinoma · congenital aortic valve stenosis · congestive heart failure · craniosynostosis · Crohn disease · female reproductive organ cancer · female reproductive system neoplasm · fibromyalgia · gastric carcinoma · idiopathic pulmonary arterial hypertension · impaired renal function disease · infertility disorder · L-ferritin deficiency · myalgic encephalomeyelitis/chronic fatigue syndrome · osteoarthritis · osteoporosis · postpartum depression · pulmonary arterial hypertension · symptomatic heart failure · thrombocytosis disease · type 2 diabetes mellitus · anemia due to chronic disorder · mild heart failure · moderate heart failure · myocardial infarction
Investigated by: American Regent, Inc. · Vifor Pharma · Asan Medical Center · Konkuk University Medical Center · University Hospital, Montpellier · University of Oxford
+135 more
· Assistance Publique - Hôpitaux de Paris · Charite University, Berlin, Germany · ClinStar, LLC · Columbia University · Helsinki University Central Hospital · ICON Clinical Research · JW Pharmaceutical · NYU Langone Health · National Cancer Center, Korea · National Institute for Health Research, United Kingdom · Nottingham University Hospitals NHS Trust · Parexel · Roche Pharma AG · Samsung Medical Center · The Catholic University of Korea · Thomas Jefferson University · University of Zurich · Ziekenhuis Oost-Limburg · Aga Khan University · Albina Nowak, MD · Amgen · Aminu Kano Teaching Hospital · Amsterdam UMC, location VUmc · Andalusian Public Foundation for Health Research in Seville · Association for the Advancement of Blood & Biotherapies · AstraZeneca · Bill and Melinda Gates Foundation · Blutspendedienst SRK Bern AG, 3008 Bern, Switzerland · Boston University · British Heart Foundation · CMH Multan Institute of Medical Sciences · Cantonal Hosptal, Baselland · Catharina Ziekenhuis Eindhoven · Centre Francois Baclesse · Children's Hospital of Orange County · Children's Investment Fund Foundation · Christian Medical College, Vellore, India · Clinical Trial Unit, University Hospital Basel, Switzerland · Clinique Pasteur · Denver Health and Hospital Authority · Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) · Dextra Fertility Clinic · Dr. med. Mahir Karakas · Duke-NUS Graduate Medical School · ESI-PGIMSR, Basaidarapur · Erasmus Medical Center · Federal Knowledge Centre (KCE) · Fundación para la Investigación del Hospital Clínico de Valencia · GBG Forschungs GmbH · GWT-TUD GmbH · Georg-Christian Funk · Hasselt University · Hikma Pharmaceuticals LLC · Hospital Aleman · Hospital Moinhos de Vento · Hospital de Clinicas de Porto Alegre · Hospital de Santa Cruz, Portugal · Humanitäre Stiftung des Schweizerischen Roten Kreuzes, 3011 Bern, Switzerland · Ifakara Health Institute · Indiana University · Insel Gruppe AG, University Hospital Bern · Institut Cancerologie de l'Ouest · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · Institute of Nutrition of Central America and Panama · International Centre for Diarrhoeal Disease Research, Bangladesh · Istanbul University · Istituto Clinico Humanitas · Jawaharlal Nehru Medical College · Jon Unosson · KLE University Jawaharlal Nehru Medical College · King Hussein Cancer Center · Kinshasa School of Public Health · Lata Medical Research Foundation, Nagpur · Liverpool Hope University · all 141 on the full record

Regulatory milestones approvals, filings & regulatory actions · 5 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Label expansions (4)	US (FDA)	INJECTAFER	—	2018-01-26 – 2023-05-31	fda.gov ↗
Approved	US (FDA)	INJECTAFER	—	2013-07-25	fda.gov ↗

Trials 128 · started per year

today

US approved 2013

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 13 trials
Phase 1	NCT03399084	Nov 2017 → Jan 2019	iron deficiency anemia	Sandoz	Completed	No outcome recorded
Phase 1	NCT02009943	Feb → Aug 2017	anemia, disorder of iron metabolism and transport	Denver Health and Hospital Authority	Withdrawn	No outcome recorded
Phase 1	NCT02737995	May 2015 → Jan 2016	heart failure	NYU Langone Health	Completed	No outcome recorded
Phase 215 trials
Phase 2	NCT04968379	Jul 2022 → Oct 2024	iron deficiency anemia	American Regent, Inc.	Withdrawn	No outcome recorded
Phase 2	NCT02949947	Dec 2017 → Mar 2019	gastrointestinal stromal tumor, malignant soft tissue neoplasm	M.D. Anderson Cancer Center	Terminated	No outcome recorded
Phase 2	NCT03218384	Sep 2017 → Apr 2022	disorder of iron metabolism and transport	NYU Langone Health	Terminated	No outcome recorded
Phase 2	NCT03050424	Apr 2017 → Oct 2018	chronic obstructive pulmonary disease	Royal Brompton & Harefield NHS Foundation Trust	Unknown	No outcome recorded
Phase 2	NCT02599012	Sep 2015 → Oct 2017	anemia, cancer	Samsung Medical Center	Unknown	No outcome recorded
Phase 2	NCT02469480	Mar 2015 → May 2020	colorectal cancer	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	Completed	No outcome recorded
Phase 2	NCT02409459	Mar → Oct 2015	disorder of iron metabolism and transport, fibromyalgia	American Regent, Inc.	Completed	No outcome recorded
Phase 2	NCT02410213	Feb 2015 → Jan 2017	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 2	NCT02517151	Oct 2014 → May 2016	inflammatory bowel disease, myalgic encephalomeyelitis/chronic fatigue syndrome	Istituto Clinico Humanitas	Unknown	No outcome recorded
Phase 2	NCT02628860	Jan 2014 → Apr 2020	anemia, malignant pancreatic neoplasm	National Cancer Center, Korea	Completed	No outcome recorded
Phase 2	NCT01307007	Sep 2010 → May 2011	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 2	NCT01290315	Aug 2009 → Mar 2013	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 2	NCT00882414	Dec 2006 → Jan 2010	iron deficiency anemia, thrombocytosis disease	Vifor Pharma	Terminated	No outcome recorded
Phase 2	NCT00685815	Nov 2006 → Dec 2010	restless legs syndrome	American Regent, Inc.	Completed	No outcome recorded
Phase 2	NCT01382901	Mar 2006 → Jul 2007	restless legs syndrome	American Regent, Inc.	Completed	No outcome recorded

Phase 2/32 trials
Phase 2/3	NCT07217873	Nov 2025 → Aug 2027 expected	adolescent idiopathic scoliosis, disorder of iron metabolism and transport	Columbia University	Recruiting	No outcome recorded
Phase 2/3	NCT07648628	Mar 2024 → Jul 2025	iron deficiency anemia	ESI-PGIMSR, Basaidarapur	Completed	No outcome recorded
Phase 339 trials
Phase 3	NCT05744219	Sep 2024 → Dec 2027 expected	aortic aneurysm, liver cancer, malignant pancreatic neoplasm	Jon Unosson	Recruiting	No outcome recorded
Phase 3	NCT06434025	May 2024 → May 2026 overdue	iron metabolism disease, systolic heart failure	Hospital de Clinicas de Porto Alegre	Not yet recruiting	No outcome recorded
Phase 3	NCT05590260	May 2023 → Mar 2025	—	NICHD Global Network for Women's and Children's Health	Completed	No outcome recorded
Phase 3	NCT05226169	Apr 2022 → Nov 2026 expected	gastric carcinoma	Asan Medical Center	Recruiting	No outcome recorded
Phase 3	NCT04976179	Aug 2021 → Apr 2023	iron deficiency anemia	University of Lagos, Nigeria	Completed	No outcome recorded
Phase 3	NCT04625530	Aug 2021 → Dec 2026	female reproductive system neoplasm	University Hospital, Basel, Switzerland	Withdrawn	No outcome recorded
Phase 3	NCT03957057	Sep 2020 → Apr 2022	deficiency anemia, iron deficiency anemia	University Medical Centre Ljubljana	Completed	No outcome recorded
Phase 3	NCT04187716	Feb → Dec 2020	anemia	Samsung Medical Center	Unknown	No outcome recorded
Phase 3	NCT04269707	Nov 2019 → Dec 2020	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT03991000	Feb 2019 → Dec 2021	acute myocardial infarction, atrial fibrillation, iron deficiency anemia, systolic heart failure	Dr. med. Mahir Karakas	Terminated	No outcome recorded
Phase 3	NCT03591406	Jul 2017 → Feb 2019	iron deficiency anemia	Vifor (International) Inc.	Completed	No outcome recorded
Phase 3	NCT02541708	Sep 2015 → Apr 2018	iron deficiency anemia	Ifakara Health Institute	Unknown	No outcome recorded
Phase 3	NCT02453334	May 2015 → Jan 2018	chemotherapy-induced toxicity	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT02125344	Dec 2014 → Nov 2016	HER2 positive breast carcinoma, breast mucinous carcinoma, female breast carcinoma, inflammatory breast carcinoma +1	GBG Forschungs GmbH	Completed	No outcome recorded
Phase 3	NCT01787526	Jun 2014 → Aug 2016	iron deficiency anemia	Medical University of Graz	Completed	No outcome recorded
Phase 3	NCT01692418	Jan 2014 → May 2019	anemia	University College, London	Completed	No outcome recorded
Phase 3	NCT01690585	Jan 2013 → Jul 2017	anemia	University Hospital, Rouen	Completed	No outcome recorded
Phase 3	NCT01725789	Nov 2012 → Apr 2016	anemia	National Cancer Center, Korea	Completed	No outcome recorded
Phase 3	NCT01513369	Aug 2012 → Oct 2018	disorder of iron metabolism and transport, type 2 diabetes mellitus	GWT-TUD GmbH	Completed	No outcome recorded
Phase 3	NCT01394562	Jul 2011 → May 2016	disorder of iron metabolism and transport, heart failure	Vifor Pharma	Completed	No outcome recorded
Phase 3	NCT01154491	Jun 2010 → May 2013	osteoporosis	Andalusian Public Foundation for Health Research in Seville	Completed	No outcome recorded
Phase 3	NCT00994318	Dec 2009 → Feb 2013	chronic kidney disease, iron deficiency anemia	Vifor Pharma	Completed	No outcome recorded
Phase 3	NCT00982007	Sep 2009 → Mar 2011	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00981045	Aug 2009 → Jul 2011	impaired renal function disease, iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00810004	Feb 2009 → Oct 2010	disorder of iron metabolism and transport, inflammatory bowel disease	Vifor Pharma	Completed	No outcome recorded
Phase 3	NCT00821717	Dec 2008 → Oct 2009	disorder of iron metabolism and transport, iron deficiency anemia, symptomatic heart failure	Vifor Pharma	Terminated	No outcome recorded
Phase 3	NCT00810030	Oct 2008 → Dec 2009	Crohn disease, disorder of iron metabolism and transport, iron deficiency anemia, ulcerative colitis	Vifor Pharma	Completed	No outcome recorded
Phase 3	NCT00703937	Jul 2008 → Jul 2009	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00704028	Jun 2008 → Jan 2010	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00704353	Jun 2008 → Jul 2009	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00548860	Oct 2007 → Mar 2009	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00548691	Oct 2007 → Jan 2009	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00520780	Apr 2007 → Jul 2009	disorder of iron metabolism and transport, heart failure, iron deficiency anemia	Vifor Pharma	Completed	No outcome recorded
Phase 3	NCT00354484	May → Dec 2006	—	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00740246	Jul 2005 → Feb 2006	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00317226	Jun 2005 → Mar 2007	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00317239	May 2005 → Feb 2007	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00395993	May 2005 → Apr 2006	anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT00396292	Feb → Nov 2005	anemia	American Regent, Inc.	Completed	No outcome recorded

Phase 451 trials
Phase 4	NCT07476859	Mar 2026 → Apr 2028 expected	acute coronary syndrome, disorder of iron metabolism and transport	Fundación para la Investigación del Hospital Clínico de Valencia	Recruiting	No outcome recorded
Phase 4	NCT07414199	Jan → Jun 2026 overdue	iron deficiency anemia	Children's Hospital of Orange County	Not yet recruiting	No outcome recorded
Phase 4	NCT07359599	Jan 2026 → Jul 2028 expected	disorder of iron metabolism and transport, pulmonary hypertension	Ziekenhuis Oost-Limburg	Recruiting	No outcome recorded
Phase 4	NCT06833788	Oct 2025 → Jun 2028 expected	postpartum depression	Assistance Publique - Hôpitaux de Paris	Recruiting	No outcome recorded
Phase 4	NCT07053475	Apr 2025 → Mar 2026	diastolic heart failure, disorder of iron metabolism and transport, iron deficiency anemia, systolic heart failure	Syed Hamza Mufarrih	Terminated	No outcome recorded
Phase 4	NCT07370688	Aug 2024 → Jul 2028 expected	congenital aortic valve stenosis	Erasmus Medical Center	Recruiting	No outcome recorded
Phase 4	NCT06350955	May 2024 → Jun 2026 overdue	hypophosphatemia	Lucie Favre	Recruiting	No outcome recorded
Phase 4	NCT06911034	Feb → Jul 2024	iron deficiency anemia, pregnancy disorder	CMH Multan Institute of Medical Sciences	Completed	No outcome recorded
Phase 4	NCT05816265	Jan 2024 → Mar 2026 overdue	heart failure, iron metabolism disease	Radha Gopalan	Enrolling by invitation	No outcome recorded
Phase 4	NCT06080893	Oct 2023 → Jun 2024	anemia, bone disorder	Istanbul University	Completed	No outcome recorded
Phase 4	NCT05708170	Jan 2023 → Aug 2026 overdue	iron deficiency anemia	Liverpool Hope University	Not yet recruiting	No outcome recorded
Phase 4	NCT05759078	Sep 2022 → Dec 2026 expected	acute myocardial infarction	Wroclaw Medical University	Recruiting	No outcome recorded
Phase 4	NCT05114278	Jul 2022	celiac disease	Assistance Publique - Hôpitaux de Paris	Terminated	No outcome recorded
Phase 4	NCT06686693	Apr 2022 → Sep 2025 overdue	—	United States Army Research Institute of Environmental Medicine	Recruiting	No outcome recorded
Phase 4	NCT04786769	Jan 2022 → Jan 2025	aortic valve stenosis, disorder of iron metabolism and transport	Hospital de Santa Cruz, Portugal	Unknown	No outcome recorded
Phase 4	NCT05477498	Dec 2021 → Aug 2022	diastolic heart failure, disorder of iron metabolism and transport	Cantonal Hosptal, Baselland	Withdrawn	No outcome recorded
Phase 4	NCT05358509	Mar 2021 → Dec 2023	iron deficiency anemia	Thomas Jefferson University	Completed	No outcome recorded
Phase 4	NCT04035902	Mar → Dec 2021	osteoarthritis, hip	Konkuk University Medical Center	Unknown	No outcome recorded
Phase 4	NCT04627181	Nov 2020 → Mar 2021	deficiency anemia, iron deficiency anemia	Christian Medical College, Vellore, India	Unknown	No outcome recorded
Phase 4	NCT04616092	Nov 2020 → Nov 2022	brain aneurysm, iron deficiency anemia	Seoul National University Hospital	Unknown	No outcome recorded
Phase 4	NCT04510870	Aug 2020 → Dec 2021	disorder of iron metabolism and transport, infertility disorder	Dextra Fertility Clinic	Unknown	No outcome recorded
Phase 4	NCT05429749	Jul 2020 → Dec 2023	—	Seoul National University Bundang Hospital	Unknown	No outcome recorded
Phase 4	NCT04168346	Nov 2019 → Nov 2021 overdue	gastric cancer, iron deficiency anemia	Helsinki University Central Hospital	Not yet recruiting	No outcome recorded
Phase 4	NCT03871699	Aug 2019 → Dec 2020	systolic heart failure	Hospital Moinhos de Vento	Unknown	No outcome recorded
Phase 4	NCT03632525	Feb 2019 → Mar 2020	cystic fibrosis, disorder of iron metabolism and transport	University of Oxford	Completed	No outcome recorded
Phase 4	NCT04898569	Feb 2019 → Oct 2022	coronary artery disorder	Yonsei University	Unknown	No outcome recorded
Phase 4	NCT03574311	Oct 2018 → Dec 2022	aortic valve stenosis, coronary artery disorder, mitral valve disorder, thoracic aortic aneurysm	Turku University Hospital	Unknown	No outcome recorded
Phase 4	NCT03561506	Jun 2018 → Jun 2019	osteoarthritis, knee	The Catholic University of Korea	Unknown	No outcome recorded
Phase 4	NCT03561480	Jun 2018 → Jun 2019	osteoarthritis, knee	The Catholic University of Korea	Unknown	No outcome recorded
Phase 4	NCT03295851	Nov 2017 → Mar 2019	anemia	Singapore General Hospital	Unknown	No outcome recorded
Phase 4	NCT03305705	Oct 2017 → Aug 2019	disorder of iron metabolism and transport	Albina Nowak, MD	Unknown	No outcome recorded
Phase 4	NCT03380520	Oct 2017 → Dec 2020	heart failure	Hasselt University	Completed	No outcome recorded
Phase 4	NCT03036462	Mar 2017 → May 2024	disorder of iron metabolism and transport, systolic heart failure	University Medical Center Hamburg-Eppendorf	Completed	No outcome recorded
Phase 4	NCT03042130	Dec 2016 → Feb 2018	congestive heart failure	Tel-Aviv Sourasky Medical Center	Withdrawn	No outcome recorded
Phase 4	NCT02544464	Aug 2016 → Dec 2018	osteoarthritis	Konkuk University Medical Center	Completed	No outcome recorded
Phase 4	NCT02416778	Feb 2015 → Feb 2017	chronic obstructive pulmonary disease	Georg-Christian Funk	Unknown	No outcome recorded
Phase 4	NCT02210949	Aug 2014 → Apr 2017	iron deficiency anemia, postoperative ventricular dysfunction	Catharina Ziekenhuis Eindhoven	Terminated	No outcome recorded
Phase 4	NCT01922479	Sep 2013 → Sep 2015	anemia, disorder of iron metabolism and transport, heart failure	National University Hospital, Singapore	Completed	No outcome recorded
Phase 4	NCT01950247	Aug 2013 → May 2015	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 4	NCT02213653	Apr 2013 → Nov 2014	lymphoid system disorder, metastatic malignant neoplasm	Centre Francois Baclesse	Terminated	No outcome recorded
Phase 4	NCT01374776	Feb 2013 → Sep 2014	L-ferritin deficiency	University of Zurich	Completed	No outcome recorded
Phase 4	NCT01701310	Apr 2012 → Dec 2014	anemia, colorectal carcinoma	Nottingham University Hospitals NHS Trust	Completed	No outcome recorded
Phase 4	NCT01519830	Jan 2012 → Jan 2013	—	Insel Gruppe AG, University Hospital Bern	Completed	No outcome recorded
Phase 4	NCT01453608	Oct 2011 → Feb 2014	disorder of iron metabolism and transport, heart failure	Vifor Pharma	Completed	No outcome recorded
Phase 4	NCT01345968	Jun 2011 → Jan 2013	anemia	University Hospital Muenster	Terminated	No outcome recorded
Phase 4	NCT02232906	Mar 2011 → Sep 2013	anemia, disorder of iron metabolism and transport	Hospital Aleman	Completed	No outcome recorded
Phase 4	NCT01913808	Jan 2011 → Feb 2012	osteoarthritis, knee	Parc de Salut Mar	Completed	No outcome recorded
Phase 4	NCT01288651	Jan 2011 → Dec 2012	idiopathic pulmonary arterial hypertension	Amsterdam UMC, location VUmc	Unknown	No outcome recorded
Phase 4	NCT01110356	Jun 2010 → Oct 2011	disorder of iron metabolism and transport	Vifor Pharma	Completed	No outcome recorded
Phase 4	NCT01245777	Oct 2009 → Dec 2012	iron deficiency anemia, restless legs syndrome	University of Zurich	Completed	No outcome recorded
Phase 4	NCT02057471	Sep 2009 → Jan 2011	anemia, colorectal neoplasm	Nottingham University Hospitals NHS Trust	Completed	No outcome recorded

Phase not applicable18 trials
—	NCT07057973	Jul 2025 → Jul 2026 overdue	—	Xuanwu Hospital, Beijing	Recruiting	No outcome recorded
—	NCT06994065	Apr → Sep 2025	iron deficiency anemia	Sindh Institute of Urology and Transplantation	Completed	No outcome recorded
—	NCT07340450	Feb → Aug 2025	—	Shahida Islam Medical Complex	Completed	No outcome recorded
—	NCT07115121	Feb → Jul 2025	anemia	Muhammad Aamir Latif	Completed	No outcome recorded
—	NCT06442111	Jul 2024 → Jun 2025	—	Seoul St. Mary's Hospital	Unknown	No outcome recorded
—	NCT04343170	Sep 2023 → Sep 2024	idiopathic scoliosis, iron deficiency anemia	Tanta University	Completed	No outcome recorded
—	NCT05669872	Feb 2023 → Jun 2025	female reproductive organ cancer	Asan Medical Center	Unknown	No outcome recorded
—	NCT05636774	Dec 2022 → Jan 2025	—	University Hospital, Essen	Completed	No outcome recorded
—	NCT04653181	Oct 2020 → Dec 2024	colon carcinoma	Helsinki University Central Hospital	Unknown	No outcome recorded
—	NCT04141631	Jan 2020 → May 2022	anemia, cardiac valvular defect	University Hospital, Montpellier	Completed	No outcome recorded
—	NCT04040023	Sep 2019 → Jul 2021	—	Clinique Pasteur	Completed	No outcome recorded
—	NCT02800746	Jun → Dec 2018	—	Konkuk University Medical Center	Unknown	No outcome recorded
—	NCT03231085	Oct 2017 → Apr 2024	craniosynostosis	University Hospital, Montpellier	Completed	No outcome recorded
—	NCT04246021	Jun 2016 → Dec 2017	anemia, cancer	King Hussein Cancer Center	Completed	No outcome recorded
—	NCT03707249	Jan → May 2016	altitude sickness, cardiac ventricle disorder, iron metabolism disease, pulmonary artery disease	Royal Centre for Defence Medicine	Completed	No outcome recorded
—	NCT02496377	Aug 2014 → Oct 2016	blood group incompatibility, osteoarthritis, hip, osteoarthritis, knee	University Hospital, Montpellier	Completed	No outcome recorded
—	NCT03625661	Feb 2014 → Jun 2017	iron deficiency anemia	Institut Cancerologie de l'Ouest	Completed	No outcome recorded
—	NCT01847352	Feb 2013 → Apr 2014	disorder of iron metabolism and transport, pulmonary arterial hypertension	University of Oxford	Completed	No outcome recorded

Also used as a comparator or background therapy in 52 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 11 trial
Phase 1	NCT07384663 Comparator	Jun → Nov 2025	iron deficiency anemia	Dr Salaha Azam	Completed	No outcome recorded
Phase 23 trials
Phase 2	NCT02826681 Comparator	Jul 2017 → Sep 2021	restless legs syndrome	American Regent, Inc.	Terminated	No outcome recorded
Phase 2	NCT03079518 Comparator	Mar → Oct 2017	disorder of iron metabolism and transport, systolic heart failure	RWTH Aachen University	Completed	No outcome recorded
Phase 2	NCT01447628 Comparator	Mar 2011 → Dec 2017	disorder of iron metabolism and transport, pulmonary arterial hypertension	Imperial College London	Completed	No outcome recorded
Phase 2/31 trial
Phase 2/3	NCT00929409 Comparator	Jun 2009 → Jul 2010	iron deficiency anemia, postpartum depression, puerperal disorder	Norwegian University of Science and Technology	Terminated	No outcome recorded
Phase 316 trials
Phase 3	NCT07687784 Comparator	Dec 2026 → Jun 2028 expected	iron deficiency anemia	AFT Pharmaceuticals, Ltd.	Not yet recruiting	No outcome recorded
Phase 3	NCT04087993 Comparator	May → Dec 2020	iron deficiency anemia	Dr. Frank Behrens	Withdrawn	No outcome recorded
Phase 3	NCT04587141 Comparator	Jan 2020 → Jun 2023	inflammatory bowel disease, iron deficiency anemia	Fondazione IRCCS Policlinico San Matteo di Pavia	Unknown	No outcome recorded
Phase 3	NCT03769441 Comparator	Aug 2019 → Aug 2024	disease related to transplantation, disorder of iron metabolism and transport	University Medical Center Groningen	Completed	No outcome recorded
Phase 3	NCT03523117 Comparator	Jan 2019 → Dec 2020	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT03817957 Comparator	Sep 2018 → Dec 2023	iron deficiency anemia	Prof. Dr. Frank Behrens	Completed	No outcome recorded
Phase 3	NCT03237065 Comparator	Oct 2017 → May 2018	iron deficiency anemia	Pharmacosmos A/S	Completed	No outcome recorded
Phase 3	NCT03238911 Comparator	Oct 2017 → Jun 2018	iron deficiency anemia	Pharmacosmos A/S	Completed	No outcome recorded
Phase 3	NCT03833336 Comparator	Aug 2017 → Sep 2024	diastolic heart failure, iron deficiency anemia	Institut de Recerca Biomèdica de Lleida	Completed	No outcome recorded
Phase 3	NCT03037931 Comparator	Mar 2017 → Feb 2023	disorder of iron metabolism and transport, heart failure	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT02694978 Comparator	Feb 2016 → Jan 2017	iron deficiency anemia	AMAG Pharmaceuticals, Inc.	Completed	No outcome recorded
Phase 3	NCT02680756 Comparator	Jan 2016 → Oct 2018	Crohn disease, iron deficiency anemia	Shield Therapeutics	Completed	No outcome recorded
Phase 3	NCT02397057 Comparator	Jan 2015 → Jan 2018	restless legs syndrome	American Regent, Inc.	Completed	No outcome recorded
Phase 3	NCT01837082 Comparator	Apr 2013 → Dec 2015	anemia, congestive heart failure, disorder of iron metabolism and transport	University of Ulm	Terminated	No outcome recorded
Phase 3	NCT01101399 Comparator	May 2010 → Nov 2012	iron deficiency anemia	Vifor Pharma	Completed	No outcome recorded
Phase 3	NCT01131624 Comparator	May 2010 → May 2014	anemia	Vifor Pharma	Completed	No outcome recorded

Phase 428 trials
Phase 4	NCT05060731 Comparator	Sep 2025 → Dec 2027 expected	anemia	University of Pecs	Not yet recruiting	No outcome recorded
Phase 4	NCT05702970 Comparator	Jan 2024 → Apr 2025	disorder of iron metabolism and transport, mild heart failure, moderate heart failure, systolic heart failure +1	University of Padova	Unknown	No outcome recorded
Phase 4	NCT06061393 Comparator	Oct 2023 → Sep 2025	iron deficiency anemia	Western Galilee Hospital-Nahariya	Unknown	No outcome recorded
Phase 4	NCT05793996 Comparator	Apr 2023 → Dec 2026 expected	disorder of iron metabolism and transport, heart failure	Tomsk National Research Medical Center of the Russian Academy of Sciences	Recruiting	No outcome recorded
Phase 4	NCT04475887 Comparator	Jul 2020 → Dec 2022	—	Medical University of Vienna	Unknown	No outcome recorded
Phase 4	NCT03680456 Comparator	Mar 2020 → Jan 2025	anemia	Kepler University Hospital	Completed	No outcome recorded
Phase 4	NCT04083755 Comparator	Aug 2019 → Jun 2025	anemia, peripheral arterial occlusive disease 1	Biobizkaia Health Research Institute	Unknown	No outcome recorded
Phase 4	NCT04862715 Comparator	Apr 2019 → Dec 2021	chronic kidney disease, iron metabolism disease	King's College Hospital NHS Trust	Completed	No outcome recorded
Phase 4	NCT03759964 Comparator	Dec 2018 → Dec 2020	iron deficiency anemia	St Joseph University, Beirut, Lebanon	Completed	No outcome recorded
Phase 4	NCT03466983 Comparator	May 2018 → May 2020	inflammatory bowel disease	Pharmacosmos A/S	Completed	No outcome recorded
Phase 4	NCT03388385 Comparator	Sep 2017 → Dec 2020	anemia, disorder of defective peroxisome oxidative status, iron poisoning	Carol Davila University of Medicine and Pharmacy	Unknown	No outcome recorded
Phase 4	NCT03074591 Comparator	Aug 2017 → Dec 2022	disorder of iron metabolism and transport, heart failure	Charite University, Berlin, Germany	Completed	No outcome recorded
Phase 4	NCT03191201 Comparator	Jun 2017 → Mar 2020	glucose metabolism disease, iron deficiency anemia, iron poisoning	Prof Gérard WAEBER	Terminated	No outcome recorded
Phase 4	NCT03398681 Comparator	May 2017 → Jul 2018	disorder of iron metabolism and transport, heart failure	Fundación para la Investigación del Hospital Clínico de Valencia	Completed	No outcome recorded
Phase 4	NCT02937454 Comparator	Apr 2017 → Jul 2020	disorder of iron metabolism and transport, heart failure	Vifor (International) Inc.	Completed	No outcome recorded
Phase 4	NCT02939794 Comparator	Nov 2016 → Aug 2018	anemia	Rambam Health Care Campus	Unknown	No outcome recorded
Phase 4	NCT02632760 Comparator	Jul 2016 → Apr 2024	anemia	Bayside Health	Completed	No outcome recorded
Phase 4	NCT02905539 Comparator	Jul 2016 → Jun 2020	iron deficiency anemia	Saarland University	Completed	No outcome recorded
Phase 4	NCT01975272 Comparator	Mar 2015 → May 2018	—	Maastricht University Medical Center	Terminated	No outcome recorded
Phase 4	NCT02271997 Comparator	Dec 2014 → Jun 2017	disorder of iron metabolism and transport	Rijnstate Hospital	Completed	No outcome recorded
Phase 4	NCT02243735 Comparator	Nov 2014 → Nov 2019	anemia, colorectal carcinoma	Academic Medical Center - University of Amsterdam	Unknown	No outcome recorded
Phase 4	NCT02198495 Comparator	Sep 2014 → May 2019	anemia due to chronic disorder	Medical University of Vienna	Completed	No outcome recorded
Phase 4	NCT02086968 Comparator	Jan 2014 → Jul 2016	iron deficiency anemia	American Regent, Inc.	Completed	No outcome recorded
Phase 4	NCT02031289 Comparator	Dec 2013 → Dec 2017	anemia, disorder of iron metabolism and transport	University of Zurich	Completed	No outcome recorded
Phase 4	NCT01978028 Comparator	Oct 2013 → Dec 2017	heart failure	University of Zurich	Terminated	No outcome recorded
Phase 4	NCT00978575 Comparator	Apr 2010 → Jan 2013	anemia	University of Aarhus	Completed	No outcome recorded
Phase 4	NCT01100879 Comparator	Mar 2010 → Jul 2011	iron deficiency anemia	Vifor Pharma	Terminated	No outcome recorded
Phase 4	NCT00706667 Comparator	May 2008 → Dec 2012	iron deficiency anemia	University of Zurich	Terminated	No outcome recorded

Phase not applicable3 trials
—	NCT06437080 Comparator	Oct 2022 → Oct 2025	disorder of iron metabolism and transport, iron metabolism disease	Akram Medical Complex	Completed	No outcome recorded
—	NCT05309499 Comparator	Dec 2021 → Sep 2025	iron deficiency anemia, myocardial infarction	Kazan State Medical University	Completed	No outcome recorded
—	NCT02308449 Comparator	Oct 2014 → Dec 2015	disorder of iron metabolism and transport	University of Oxford	Completed	No outcome recorded

Press releases naming this drug 13 releases

Date	Issuer	Release
2024-03-19	CSL Behring	Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure csl.com ↗
2023-08-28	CSL Behring	Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines csl.com ↗
2023-06-05	CSL Behring	Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure csl.com ↗
2022-11-28	CSL Behring	Ferinject® approved in China for the treatment of iron deficiency in adult patients csl.com ↗
2021-12-20	CSL Behring	Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation csl.com ↗
2021-08-31	CSL Behring	Vifor Pharma’s Ferinject® granted new recommendations in updated 2021 ESC heart failure guidelines csl.com ↗
2020-11-13	CSL Behring	Full Results From Affirm-ahf Study Show Ferinject® Significantly Reduces Hospitalizations After Acute Heart Failure in Patients With Iron Deficiency csl.com ↗
2013-07-26	Daiichi Sankyo	Injectafer® (ferric carboxymaltose injection) receives US FDA approval for the treatment of Iron Deficiency Anemia daiichisankyo.com ↗
2012-07-26	Daiichi Sankyo	Luitpold Pharmaceuticals, Inc. Receives Complete Response Letter for Injectafer(R) from the U.S. Food and Drug Administration daiichisankyo.com ↗
2011-10-13	Daiichi Sankyo	Luitpold Pharmacueticals, Inc. Submits Injectafer(R) NDA to the U.S. Food and Drug Administration daiichisankyo.com ↗
2008-03-12	Daiichi Sankyo	Luitpold Pharmaceutical's INJECTAFER(TM) (ferric carboxymaltose injection) receives non-approvable letter from FDA daiichisankyo.com ↗
2008-02-04	Daiichi Sankyo	FDA Advisory Committee Supports Favorable Risk-Benefit Profile for Injectafer(TM)(Ferric Carboxymaltose Injection) Under Certain Indications for Use daiichisankyo.com ↗
2007-05-14	Daiichi Sankyo	Announce on NDA Submission for Injectafer® daiichisankyo.com ↗

Evidence & citations 18 cited values

Every value below carries the sentence it was read from. 190 sources stand behind the page.

Field	Value	Cited text
Known as	ferric carboxymaltose	“Participants received Intravenous iron i.e ferric carboxymaltose (≤1,000 mg) were given to patients in Group "A" either as a single dose or as two doses spaced three days apart...” NCT07340450 ↗ 153 “Phase IV Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated...” NCT02213653 ↗ “Conclusions. This study will determine the eﬀect of ferric carboxymaltose and its combination with SGLT2i on LVEF and its relationship with measures of myocardial iron content,...” NCT06434025 ↗ “Administration of ferric carboxymaltose (n = 558) initially given at an intravenous dose of up to 2000 mg that was followed by 500 mg every 4 months (unless stopping criteria...” PMID 40159390 ↗ Jun 2025 “This is a clinical trial to evaluate the effect of intravenous iron supplement with Ferinject (Ferric Carboxymaltose) in preventing postoperative delirium after hip fracture surgery.” NCT05429749 ↗ “AIM: To compare the efficacy of oral ferrous fumarate (FF), oral ferrous gluconate (FG), and a single intravenous infusion of ferric carboxymaltose (FCM) in women with ID after RYGB.” PMID 32402684 ↗ Apr 2020 “Before surgery, if a patient had iron deficiency anemia, the patient was randomized to receive Ferinject®(Ferric carboxymaltose, n=50) or placebo (normal saline, n=50), respectively.” NCT04898569 ↗ “Ferric carboxymaltose will be provided in 2 vials of 10 mL containing each 500 mg iron, which will be diluted in 250 mL normal saline for injection.” NCT01110356 ↗ “we compared rates of hypophosphatemia in response to a single FDA-approved course of ferric carboxymaltose (n = 1,000) or ferumoxytol (n = 997).” PMID 30518682 ↗ Dec 2018 “IV ferric carboxymaltose (less than or equal to 1,000 mg over 15 minutes, repeated weekly to achieve a total calculated replacement dose)” PMID 17666600 ↗ Aug 2007 “Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency.” PMID 32067585 ↗ Feb 2020 “This study aimed to evaluate prospectively the efficacy of ferric carboxymaltose to treat anaemia in older patients after AGIB.” PMID 38706390 ↗ May 2024 “Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery” NCT00706667 ↗ “Comparison of Ferric Carboxymaltose Versus Iron Sucrose for Treatment of Iron Deficiency Anemia in Pregnant Women” NCT06911034 ↗ “1000 mg of ferric carboxymaltose \[Ferinject™, Vifor Pharma, Glattbrugg, Dwitzerland\], inject over 15 minutes” NCT06442111 ↗ “using intravenous iron (1000 mg ferric carboxymaltose) and erythropoietin-α (600 IU/kg weekly, 1-3 doses).” PMID 41483954 ↗ Nov 2025 “preoperative intravenous ferric carboxymaltose in patients with anemia undergoing hip or knee replacement” NCT01345968 ↗ “One dose of intravenous 1000 mg ferric carboxymaltose will be administered on the day of randomization.” NCT05060731 ↗ “FerInject: max. 2.000 mg of ferric carboxymaltose over max. 2 weeks (max. 1.000 mg per week).” NCT02469480 ↗ “Combination of Sacubitril/valsartan, Ivabradine, Ferric carboxymaltose and/or Empagliflozin.” NCT05636774 ↗ “Medication name: Ferinject® Active ingredient: Ferric carboxymaltose” NCT04862715 ↗ “Intravenous Ferric Carboxymaltose (FERINJECT®) Versus Placebo” NCT00810004 ↗ “Ferric Carboxymaltose, an intravenous iron therapy” NCT01131624 ↗ “single dose of 500 mg ferric carboxymaltose” NCT06350955 ↗ “Single dose of 500 mg Ferric carboxymaltose” NCT07384663 ↗ “Ferinject ® (Ferric carboxymaltose)” NCT00821717 ↗ “FERINJECT® (Ferric carboxymaltose)” NCT00882414 ↗ “Injectafer (Ferric Carboxymaltose)” NCT02397057 ↗ “Intravenous ferric carboxymaltose.” NCT03231085 ↗ “Ferinject (ferric carboxymaltose)” NCT01394562 ↗ “Ferinject (Ferric Carboxymaltose)” NCT02628860 ↗ “ferric carboxymaltose (Ferinject)” PMID 33735594 ↗ Jun 2021 “Ferinject (ferric carboxymaltose)” NCT01453608 ↗ “ferric carboxymaltose (Iroprem®)” NCT03957057 ↗ “Ferric carboxymaltose injection” NCT05816265 ↗ “Drug: Ferric Carboxy Maltose” NCT07340450 ↗ “Ferric carboxymaltose” NCT05793996 ↗ “ferric carboxymaltose” NCT02939794 ↗ NCT03833336 ↗ NCT05669872 ↗ NCT04343170 ↗ NCT01382901 ↗ NCT03238911 ↗ NCT01837082 ↗ NCT04627181 ↗ NCT04968379 ↗ NCT02937454 ↗ NCT01307007 ↗ NCT02308449 ↗ NCT01100879 ↗ NCT00982007 ↗ NCT05590260 ↗ NCT03769441 ↗ NCT02737995 ↗ NCT04087993 ↗ NCT03237065 ↗ NCT07414199 ↗ NCT03591406 ↗ NCT07648628 ↗ NCT01978028 ↗ NCT03466983 ↗ NCT03037931 ↗ NCT03707249 ↗ NCT03632525 ↗ NCT03991000 ↗ NCT04141631 ↗ NCT01701310 ↗ NCT00994318 ↗ NCT07476859 ↗ NCT04587141 ↗ NCT01245777 ↗ NCT03680456 ↗ NCT00548691 ↗ NCT07217873 ↗ NCT00548860 ↗ NCT05358509 ↗ NCT02544464 ↗ NCT01922479 ↗ NCT00703937 ↗ NCT00704028 ↗ NCT03574311 ↗ NCT07057973 ↗ NCT02541708 ↗ NCT03191201 ↗ NCT01913808 ↗ NCT00317239 ↗ NCT06080893 ↗ NCT04786769 ↗ NCT04653181 ↗ NCT07053475 ↗ NCT03295851 ↗ NCT02410213 ↗ NCT07370688 ↗ NCT04625530 ↗ NCT00354484 ↗ NCT02632760 ↗ NCT03871699 ↗ NCT02826681 ↗ NCT03817957 ↗ NCT06437080 ↗ NCT04246021 ↗ NCT03050424 ↗ NCT00395993 ↗ NCT03218384 ↗ NCT01692418 ↗ NCT02198495 ↗ NCT00704353 ↗ NCT07115121 ↗ NCT06833788 ↗ NCT04168346 ↗ NCT00810030 ↗ NCT01101399 ↗ NCT04035902 ↗ NCT02517151 ↗ NCT07687784 ↗ NCT02125344 ↗ NCT01513369 ↗ NCT00520780 ↗ NCT05702970 ↗ NCT05744219 ↗ NCT02416778 ↗ NCT01787526 ↗ NCT00981045 ↗ NCT04083755 ↗ NCT04269707 ↗ NCT02496377 ↗ NCT04510870 ↗ NCT03523117 ↗ NCT01154491 ↗ NCT02031289 ↗ NCT03079518 ↗ NCT02009943 ↗ NCT00685815 ↗ NCT03561480 ↗ NCT05477498 ↗ NCT02905539 ↗ NCT01290315 ↗ NCT03561506 ↗ NCT03380520 ↗ NCT02800746 ↗ NCT07359599 ↗ NCT02232906 ↗ NCT02057471 ↗ NCT03074591 ↗ NCT00317226 ↗ NCT02680756 ↗ NCT02949947 ↗ NCT00929409 ↗ NCT04976179 ↗ NCT03759964 ↗ NCT05309499 ↗ NCT06994065 ↗ NCT03399084 ↗ NCT01847352 ↗
Known as	Carboximaltosa ferrica	ChEMBL registry synonym — accepted as the source's own label CHEMBL2108597 ↗
Known as	carboxymaltose ferric	“Carboxymaltose ferric (Ferinject ®) at week 1; Intravenous infusion not exceeding 1000 mg” NCT02213653 ↗
Known as	Carboxymaltose ferrique	ChEMBL registry synonym — accepted as the source's own label CHEMBL2108597 ↗
Known as	Encicarb	“Single dose of ferric carboxymaltose (Encicarb, Emcure Pharmaceuticals Ltd., Pune, India) 500 mg administered intravenously in 100 ml normal saline over 1 hour via the dialysis...” NCT04627181 ↗
Known as	FCM	“BACKGROUND: Despite preoperative anaemia treatment, a risk of postoperative anaemia remains. This randomized, controlled study evaluated the efficacy of i.v. ferric...” PMID 24780615 ↗ Apr 2014 33 “Objective. To evaluate safety and efficacy of intravenous ferric carboxymaltose (FCM) versus standard medical care (SMC) for iron-deficiency anemia (IDA) in postpartum women...” PMID 28487769 ↗ Apr 2017 “We performed a randomized, placebo-controlled trial to determine if administration of ferric carboxymaltose (FCM) prevents anemia in patients with IBD and low levels of serum ferritin.” PMID 23078888 ↗ Oct 2012 “AIM: To compare the efficacy of oral ferrous fumarate (FF), oral ferrous gluconate (FG), and a single intravenous infusion of ferric carboxymaltose (FCM) in women with ID after RYGB.” PMID 32402684 ↗ Apr 2020 “The intervention involves the administration of intravenous ferric carboxymaltose (FCM) to correct iron deficiency (ID) in patients with severe aortic stenosis.” NCT07370688 ↗ “I.v. iron administration in the form of ferric carboxymaltosis (FCM) will be carried out according to the Summary of Product Characteristics (SmPC).” NCT03036462 ↗ “Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency.” PMID 32067585 ↗ Feb 2020 “97 patients received 1 g of ferric carboxymaltose (FCM) and 98 patients received 100 mL of physiological serum on postoperative day 1” PMID 36375780 ↗ Nov 2022 “This course of FCM will consist of two doses of FCM at 15 mg/kg (maximum single dose of 750 mg), separated by seven days.” NCT04269707 ↗ “The study the effect of ferric carboxymaltose (FCM) on cardiac reverse remodelling and contractile status in HFrEF.” PMID 34185066 ↗ Dec 2021 “Ferric carboxymaltose (FCM), 1000 mg iron element will be administered once by drip infusion (Intravenous route).” NCT03191201 ↗ “To evaluate the effect of intravenous ferric carboxymaltose (IV FCM) in iron deficient subjects with AHF” NCT02937454 ↗ “Ferric carboxymaltose (FCM) (Ferinject / Injectafer) targeting ferritin level of 400 - 600 mcg/L” NCT00994318 ↗ “750 mg undiluted slow IVpush (100 mg/minute) of Injectafer® (Ferric Carboxymaltose - FCM)” NCT02826681 ↗ “Ferric Carboxymaltose (FCM) (20 mg/kg in 250 mL of saline solution 0.9% over 15 min)” NCT04141631 ↗ “Ferric Carboxymaltose (FCM), dosing and administration according to SmPC guidelines” NCT07359599 ↗ “single-dose intravenous ferric carboxymaltose (FCM)” PMID 24751822 ↗ Apr 2014 “Ferric carboxymaltose (FCM) and folic acid tablets” NCT05590260 ↗ “Ferric carboxymaltose (FCM) dose of 1,000 mg iron” NCT02232906 ↗ “Ferric Carboxymaltose (FCM)” NCT01307007 ↗ “Ferric Carboxymaltose (FCM)” NCT00981045 ↗ “Ferric Carboxymaltose (FCM)” NCT01382901 ↗ “Ferric Carboxymaltose (FCM)” NCT00317239 ↗ “Ferric Carboxymaltose (FCM)” NCT01290315 ↗ “Ferric Carboxymaltose (FCM)” NCT07648628 ↗ “Ferric Carboxymaltose (FCM)” NCT00395993 ↗ “Ferric carboxymaltose (FCM)” NCT04246021 ↗ “Ferric Carboxymaltose (FCM)” NCT00354484 ↗ “Ferric Carboxymaltose (FCM)” NCT00317226 ↗ “ferric carboxymaltose (FCM)” NCT02410213 ↗ “Ferric Carboxymaltose (FCM)” NCT06994065 ↗ “Ferric Carboxymaltose (FCM)” NCT00704028 ↗ “Ferric Carboxymaltose (FCM)” NCT00703937 ↗ “Ferric Carboxymaltose (FCM)” NCT00982007 ↗
Known as	Ferinject	“Ferric carboxymaltose 20 mg/kg (with a maximum dose of 1000 mg ferric carboxymaltose in a single Infusion) (Ferinject® 1000 mg/20ml, Vifor (International) AG, St. Gallen,...” NCT04625530 ↗ 38 “Intravenous Iron-induced Hypophosphatemia in Patients With Roux-en-Y Gastric Bypass: a Single-blind, Randomized Clinical Trial Comparing Iron Isomaltoside (Monofer®) and Ferric...” NCT06350955 ↗ “Before surgery, if a patient had iron deficiency anemia, the patient was randomized to receive Ferinject®(Ferric carboxymaltose, n=50) or placebo (normal saline, n=50), respectively.” NCT04898569 ↗ “Ferric carboxymaltose (Ferinject®, Vifor-France) was given as a single i.v. dose to correct the total iron deficit calculated by the Ganzoni formula” NCT01913808 ↗ “Single intravenous administration of ferric carboxymaltose (Ferinject®) given at baseline within 15 days after the index acute coronary syndrome.” NCT07476859 ↗ “Ferinject®: Ferric carboxymaltose: 2 vials of 10 mL containing each 500 mg iron, diluted in 250 mL normal saline for injection.” NCT01154491 ↗ “Ferric carboxymaltose (Ferinject, Vifor (International) AG, St. Gallen) 1000 mg in 100 ml sodiumchloride (NaCl) over 30 min.” NCT02031289 ↗ “From November 2018 to April 2019, FERINJECT 500mg was administered to 12 patients who underwent clipping surgery for UIAs.” NCT04616092 ↗ “1000 mg of ferric carboxymaltose \[Ferinject™, Vifor Pharma, Glattbrugg, Dwitzerland\], inject over 15 minutes” NCT06442111 ↗ “FerInject: max. 2.000 mg of ferric carboxymaltose over max. 2 weeks (max. 1.000 mg per week).” NCT02469480 ↗ “Ferricarboxymaltose (Ferinject®, Vifor Pharma) is used for intravenous iron administration.” NCT01288651 ↗ “Carboxymaltose ferric (Ferinject ®) at week 1; Intravenous infusion not exceeding 1000 mg” NCT02213653 ↗ “as ferric carboxymaltose (Ferinject) is better tolerated compared to oral supplementation” NCT04141631 ↗ “Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery” NCT01345968 ↗ “15mg/kg of iron as iron carboxymaltose Ferinject® in 250 ml 0.9% NaCl intravenously” NCT01374776 ↗ “Medication name: Ferinject® Active ingredient: Ferric carboxymaltose” NCT04862715 ↗ “Drug: ferric carboxymaltose Ferinject” NCT02496377 ↗ “Ferinject ® (Ferric carboxymaltose)” NCT00520780 ↗ “Iron carboxymaltose (Ferinject)” NCT01519830 ↗ NCT06061393 ↗ NCT05708170 ↗ NCT01394562 ↗ NCT00821717 ↗ NCT05226169 ↗ NCT02599012 ↗ NCT01453608 ↗ NCT05793996 ↗ NCT01447628 ↗ NCT04187716 ↗ NCT05429749 ↗ NCT05114278 ↗ NCT02939794 ↗ NCT02628860 ↗ NCT05759078 ↗ NCT03388385 ↗ NCT00882414 ↗ NCT01725789 ↗ NCT03625661 ↗ NCT01975272 ↗
Known as	Ferric Carboxymaltose (FCM)	“Ferric Carboxymaltose (FCM)” NCT02409459 ↗
Known as	ferric(III) carboxymaltose	“The intervention arm will receive 10 mL of ferric(III) carboxymaltose (50 mg Fe3/mL, intravenously) every six weeks, with a total of four dosages.” NCT03769441 ↗ 1 NCT02243735 ↗
Known as	ferricarboxymaltose	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00978575 ↗ 1 NCT01288651 ↗
Known as	Injectafer	“Subjects with functional iron deficiency determined by the results of iron biomarker results at Visit 2 will receive a single dose of intravenous ferric carboxymaltose . The...” NCT02737995 ↗ 9 “750 mg undiluted slow IVpush (100 mg/minute) of Injectafer® (Ferric Carboxymaltose - FCM)” NCT02826681 ↗ “Ferric Carboxymaltose (Injectafer) administered IV” NCT03466983 ↗ “Ferric Carboxymaltose Injection [Injectafer]” NCT04083755 ↗ NCT02397057 ↗ NCT02409459 ↗ NCT02086968 ↗ NCT02453334 ↗ NCT01950247 ↗ NCT06686693 ↗
Known as	iron carboxymaltose	“therapy with i.v. iron (iron carboxymaltose)” NCT03991000 ↗ 7 NCT03957057 ↗ NCT03305705 ↗ NCT03042130 ↗ NCT01374776 ↗ NCT04475887 ↗ NCT01519830 ↗ NCT06350955 ↗
Known as	Iron dextri-maltose	ChEMBL registry synonym — accepted as the source's own label CHEMBL2108597 ↗
Known as	Iron(III)carboxymaltose	“Administration of Iron (Ferinject (iron(III)carboxymaltose)) intravenously 1000 mg once.” NCT02210949 ↗ 1 NCT02271997 ↗
Known as	Iroprem	“ferric carboxymaltose (Iroprem®)” NCT03957057 ↗
Known as	VIT-45	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00740246 ↗
Modality	Other / unclassified	“intravenous iron formulation” NCT04246021 ↗
Route	Intravenous	“15 minutes IV” NCT00317226 ↗